UK: The Carrot And The Stick

Last Updated: 8 February 2018
Article by David Robinson

This article was first published in the Physics World Focus on Biomedical Physics in 2018

A common view of patents is that they are only useful if someone tries to copy your research and product. At that point, so the thinking goes, you need to spend copious amounts of money to enforce your patent and stop them. However, in biomedical physics, as in other fields, patents are not merely a last line of defence against unscrupulous competitors. They are also a deterrent. A timely and well-constructed patent can head off competition right from the start, as it is common (and advisable) for companies to check patent records before launching a product to see if they will be free to market it without infringing other parties' intellectual-property rights.

An even less well-understood role of patents, though, is as an attractor to investors. Deterring competitors is part of this: because patent protection prevents some would-be competitors from entering a market, it is more likely that one company (and, of course, that company's savvy investors) will reap any future profits associated with the invention. However, before they can obtain patent protection, applicants must demonstrate that a technology is innovative. This fact is also attractive for investors because it helps to demonstrate the potential value associated with an investment.

Early investor support is particularly important in areas like biomedical engineering, where inventions usually require significant investment to move from the proof-of-concept phase via prototypes to viable commercial products. In addition, innovations in biomedicine demand close attention to regulatory standards designed to ensure safe and standardized product development for clinical applications. Developing new products under these conditions brings its own costs.

Bioxydyn, a magnetic resonance imaging (MRI) applications and imaging services provider, is a good example of how patents proved key to attracting investment. Founded in 2009 as a spin-out from the University of Manchester, UK, Bioxydyn uses advanced MRI technology to evaluate lung diseases, including cystic fibrosis, asthma and cancer. Although there had been plenty of academic research into the technology in the years before Bioxydyn was founded, further research identified a way to transform this technology into a clinically practical tool by, among other things, applying novel biophysical models of lung ventilation (the capacity of the lung to receive gas) and perfusion (the blood supply to the lung at the capillary level) to the information available in the images. This made it possible for those viewing the images to draw conclusions about lung health.

Once the Bioxydyn researchers had developed a technique that could prove commercially viable, Manchester's technology-transfer office encouraged them to consider the patenting process as a means of bringing their technology to market. Following seed investment from a venture-capital fund, the company secured its first service contract with a major international pharmaceutical company in 2011 and has been growing steadily ever since. It is now on the path to acquiring European regulatory approval marking for its technology and launching its first clinical product.

Protecting the right things

When looking to secure intellectual property (IP) protection, one of the first things companies need to decide (most commonly in collaboration with an external patent attorney) is exactly what to protect. Because the protection needs to provide a roadblock to competitors wanting to take unfair advantage of the work, the most common strategy is to protect the technology underlying the main product itself. However, there are strict criteria that need to be met for an invention to be considered patentable, and there are several exclusions. It is commonly believed, for example, that software cannot be patented. However, methods implemented by software can be, as long as they have "technical effect" (that is, a real-world outcome).

In Bioxydyn's case, the tools being developed for clinical use are based on software that the company has produced, which is designed to analyse magnetic-resonance images. The tools are also based on the team's knowledge about the best ways to deploy and implement this software. The company's patents cover methods embedded in this software that are primarily designed to interpret information arising from a technique known as oxygen-enhanced MRI. With complex analysis so key to physics-based engineering, patents like these – on processing methods implemented by software – will likely become more important to businesses wanting to maintain their competitive edge.

As companies grow, their product developers continue to hone existing products or diversify into new ones. To maintain a deterrent against copycat competitors and remain attractive to investors, savvy companies need to develop their patent portfolio alongside their product range. Although each new patent family requires additional expenditure, robust, well-thought-out protection can help defend or grow market share.

Since obtaining initial protection for its core oxygen-enhanced MRI technology, Bioxydyn has gone on to patent multiple developments within this area. A new version of the core technology that produces richer and more specific information is one example. Another, later example involved patenting different applications for the technology. The initial product focused on analysing oxygen transfer in the lungs alone, but subsequent iterations have gone on to produce imaging techniques that can determine whether an imaged tumour is well oxygenated, while other image-analysis techniques can map the anatomical connectivity between regions of the brain.

A final consideration when seeking patent protection is where to protect. Patents are territorial rights, so for each territory where you want to protect your invention you need a local patent. Budget constraints mean that few organizations file in every jurisdiction globally. Instead, companies look to the most commercially important jurisdictions to prioritize their filings.

Because physics-based products often require sophisticated support technology – Bioxydyn's services and software, for example, require MRI scanners – most companies in this sector choose to protect their innovations in jurisdictions that include the world's most developed economies. These are the jurisdictions where potential customers are most likely to have access to the technology required for there to be a market for those services and software. However, as developing economies continue to evolve, so does the need to consider them as jurisdictions in which to seek protection. As more jurisdictions have access to the necessary technology, so new markets open up. In addition, for biomedical applications of physics, the geographic distribution of relevant diseases may also affect the locations where seeking protection makes commercial sense.

Decisions on where to seek protection need to be made fairly early in the patent application process. There are tools to provide more time for decision-making, such as the PCT (international) application, which buys an extra 18 months before a decision on jurisdictions is required. However, after a certain point in time, the decision as to where patent protection will be sought is fixed and you cannot subsequently obtain a patent in a jurisdiction other than those already selected, even if your product suddenly enjoys commercial success there. During the process of obtaining a patent, therefore, decisions will need to be taken based not only on current commercial factors, but also on how markets will evolve in future. Striking a balance between the cost of obtaining protection in different jurisdictions and the potential benefit of having a significant competitive advantage (in the form of a barrier to entry into the market for competitors) is often difficult.

Long-term thinking

The nature of physics research means that often, a great deal of fundamental work must be completed before commercialization appears on the horizon. Even at that point, it can take many more years of engineering, investment and commercial planning to get that research out of the lab and into the real world. While the process for applying for patent protection is also complex and IP strategies need careful forethought and planning, the benefits to R&D-based companies are well-recognized. As different areas of physics research continue to develop and move from the academic sphere to commercial application, intellectual property will continue to develop as an important commercial tool. Start-ups and spin-outs considering their IP strategy from the outset will be the best placed to seize the opportunities afforded by new technologies and retain their commercial incentive for further research and development.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions